Opexa Therapeutics Inc (NASDAQ:OPXA)

Data as of Jan 30
 +0.004 / +0.57%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues348.8K348.8K307.7K307.7K
Depreciation And Amortization77.5K95.6K98.7K97.4K
Operating ExpensesGross Income----------
General Expenses4.0M3.9M4.4M4.1M
Research And Development2.8M2.8M3.4M3.2M
Total Operating Expenses4.1M4.0M4.5M4.2M
Non-Operating ExpensesOperating Income-3.8M-3.7M-4.2M-3.9M
Interest Expense On Debt9.000.000.00958.00
Other Expenses-2.2K0.000.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-3.7M-4.2M-3.9M
Net Income-3.8M-3.7M-4.2M-3.9M
Shares To Calculate EPSShares To Calculate EPS27.5M27.6M27.7M27.8M
Shares To Calculate EPS Diluted27.5M27.6M27.7M27.8M
Earnings Per ShareEPS-$0.14-$0.13-$0.15-$0.14
EPS Diluted-$0.14-$0.13-$0.15-$0.14

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.